ONO-7914 / Ono Pharma - LARVOL DELTA

Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors (clinicaltrials.gov) - P1 | N=25 | Terminated | Sponsor: Ono Pharmaceutical Co. Ltd | N=204 ➔ 25 | Trial completion date: Sep 2027 ➔ Feb 2025 | Active, not recruiting ➔ Terminated | Trial primary completion date: Mar 2027 ➔ Feb 2025; Due to strategic reasons

Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Solid Tumor

Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors (clinicaltrials.gov) - P1 | N=204 | Active, not recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Active, not recruiting

Enrollment closed • Oncology • Solid Tumor

Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors (clinicaltrials.gov) - P1 | N=204 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd

Combination therapy • Metastases • New P1 trial • Oncology • Solid Tumor